Endothelium-dependent contraction of canine coronary artery is enhanced by crystalloid cardioplegic solution
- 1 January 1995
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 109 (1) , 99-105
- https://doi.org/10.1016/s0022-5223(95)70425-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary arteryThe Journal of Thoracic and Cardiovascular Surgery, 1992
- Production of endothelium-derived contracting factor is enhanced after coronary reperfusionThe Annals of Thoracic Surgery, 1991
- Role of potassium concentration in cardioplegic solutions in mediating endothelial damageThe Annals of Thoracic Surgery, 1991
- Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heartThe Journal of Thoracic and Cardiovascular Surgery, 1989
- Endothelium-derived relaxing factor and coronary vasospasm.Circulation, 1989
- Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells.Proceedings of the National Academy of Sciences, 1988
- Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in plateletsBritish Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Endothelium‐dependent inhibition of platelet aggregationBritish Journal of Pharmacology, 1986
- Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium.The Journal of Physiology, 1985